345 related articles for article (PubMed ID: 36691324)
1. Gene therapy for hemophilia: looking beyond factor expression.
Yamaguti-Hayakawa GG; Ozelo MC
Exp Biol Med (Maywood); 2022 Dec; 247(24):2223-2232. PubMed ID: 36691324
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis and prediction of long-term durability of factor IX activity following etranacogene dezaparvovec gene therapy in the treatment of hemophilia B.
Shah J; Kim H; Sivamurthy K; Monahan PE; Fries M
Curr Med Res Opin; 2023 Feb; 39(2):227-237. PubMed ID: 36285399
[TBL] [Abstract][Full Text] [Related]
3. Hemophilia Gene Therapy: Ready for Prime Time?
VandenDriessche T; Chuah MK
Hum Gene Ther; 2017 Nov; 28(11):1013-1023. PubMed ID: 28793786
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy for Hemophilia.
Nienhuis AW; Nathwani AC; Davidoff AM
Mol Ther; 2017 May; 25(5):1163-1167. PubMed ID: 28411016
[TBL] [Abstract][Full Text] [Related]
5. Practical Implications of Factor IX Gene Transfer for Individuals with Hemophilia B: A Clinical Perspective.
Miesbach W; Sawyer EK
Hum Gene Ther Clin Dev; 2018 Jun; 29(2):80-89. PubMed ID: 29624465
[TBL] [Abstract][Full Text] [Related]
6. Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting.
Ay C; Perschy L; Rejtö J; Kaider A; Pabinger I
Ann Hematol; 2020 Dec; 99(12):2763-2771. PubMed ID: 32918114
[TBL] [Abstract][Full Text] [Related]
7. The evolution of recombinant factor replacement for hemophilia.
Sankar AD; Weyand AC; Pipe SW
Transfus Apher Sci; 2019 Oct; 58(5):596-600. PubMed ID: 31421983
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for hemophilia.
Nathwani AC
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):569-578. PubMed ID: 36485127
[TBL] [Abstract][Full Text] [Related]
9. Progress, and prospects in the therapeutic armamentarium of persons with congenital hemophilia. Defining the place for liver-directed gene therapy.
Di Minno G; Castaman G; De Cristofaro R; Brunetti-Pierri N; Pastore L; Castaldo G; Trama U; Di Minno M
Blood Rev; 2023 Mar; 58():101011. PubMed ID: 36031462
[TBL] [Abstract][Full Text] [Related]
10. Hemophilia A/B.
Croteau SE
Hematol Oncol Clin North Am; 2022 Aug; 36(4):797-812. PubMed ID: 35773055
[TBL] [Abstract][Full Text] [Related]
11. Advances in Gene Therapy for Hemophilia.
Nathwani AC; Davidoff AM; Tuddenham EGD
Hum Gene Ther; 2017 Nov; 28(11):1004-1012. PubMed ID: 28835123
[TBL] [Abstract][Full Text] [Related]
12. New and improved AAVenues: current status of hemophilia B gene therapy.
Brimble MA; Reiss UM; Nathwani AC; Davidoff AM
Expert Opin Biol Ther; 2016; 16(1):79-92. PubMed ID: 26524468
[TBL] [Abstract][Full Text] [Related]
13. Coagulation factors with improved properties for hemophilia gene therapy.
Pipe SW
Semin Thromb Hemost; 2004 Apr; 30(2):227-37. PubMed ID: 15118934
[TBL] [Abstract][Full Text] [Related]
14. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
George LA; Sullivan SK; Giermasz A; Rasko JEJ; Samelson-Jones BJ; Ducore J; Cuker A; Sullivan LM; Majumdar S; Teitel J; McGuinn CE; Ragni MV; Luk AY; Hui D; Wright JF; Chen Y; Liu Y; Wachtel K; Winters A; Tiefenbacher S; Arruda VR; van der Loo JCM; Zelenaia O; Takefman D; Carr ME; Couto LB; Anguela XM; High KA
N Engl J Med; 2017 Dec; 377(23):2215-2227. PubMed ID: 29211678
[TBL] [Abstract][Full Text] [Related]
15. Advances in gene therapy for hemophilia: basis, current status, and future perspectives.
Ohmori T
Int J Hematol; 2020 Jan; 111(1):31-41. PubMed ID: 30083852
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and treatment of osteoporosis in patients with hemophilia.
Lin X; Gao P; Zhang Q; Jiang Y; Wang O; Xia W; Li M
Arch Osteoporos; 2023 Jan; 18(1):17. PubMed ID: 36598583
[TBL] [Abstract][Full Text] [Related]
17. Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
Milanov P; Ivanciu L; Abriss D; Quade-Lyssy P; Miesbach W; Alesci S; Tonn T; Grez M; Seifried E; Schüttrumpf J
Blood; 2012 Jan; 119(2):602-11. PubMed ID: 22031860
[TBL] [Abstract][Full Text] [Related]
18. Foundations of hemophilia and epidemiology.
Quintana Paris L
Blood Coagul Fibrinolysis; 2023 Jun; 34(S1):S35-S36. PubMed ID: 37254731
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and management of hemophilia].
Tokugawa T
Rinsho Ketsueki; 2020; 61(9):1338-1348. PubMed ID: 33162534
[TBL] [Abstract][Full Text] [Related]
20. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
